Glucose monitoring without piercing the skin is a prize companies like Apple and Samsung have been aiming for. Now, Samsung has news.

Samsung is working on noninvasive blood sugar monitoring tech, which could be a game-changer. But it isn't ready for the Galaxy Watch yet.

Apple isn’t the only company said to be looking into the technology, and now it looks like Samsung may beat Apple to the punch. Originally rumored for last year’s Galaxy Watch Ultra, the company has dropped its biggest hint that the long-awaited health-tracking breakthrough is just around the corner.

Samsung has laid down the gauntlet with a bold declaration that progress on developing a non-invasive continuous glucose monitor is progressing swimmingly.

Samsung hinted at new 2025 features for Samsung Health, from "vascular load" to AI coaching, and it has me intrigued.

Amazon's Galaxy Watch FE deal drops the LTE model of the Samsung smartwatch to a record-low price of just $189.99.

Some of the Samsung Health app features unveiled at the company's Unpacked event are available immediately, while others are coming later this year.

The Apple Watch Ultra was unveiled to much fanfare in 2022, and the Apple Watch Ultra 2 built on this successful formula in 2023. Despite skipping a year in 2024, the UItra 2 remains the best smartwatch on the market by a healthy margin.

The Samsung Galaxy Watch 7 (44mm) is currently on sale for $249.99, 24% off its list price of $329.99. According to price tracker camelcamelcamel, this is also its lowest-ever price, making it a great time to jump on it before the discount disappears.